Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Mar-Apr;4(2):125-35.
doi: 10.4161/gmic.23571. Epub 2013 Jan 18.

High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria

Affiliations
Case Reports

High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria

Matthew J Hamilton et al. Gut Microbes. 2013 Mar-Apr.

Abstract

Fecal microbiota transplantation (FMT) is becoming a more widely used technology for treatment of recurrent Clostridum difficile infection (CDI). While previous treatments used fresh fecal slurries as a source of microbiota for FMT, we recently reported the successful use of standardized, partially purified and frozen fecal microbiota to treat CDI. Here we report that high-throughput 16S rRNA gene sequencing showed stable engraftment of gut microbiota following FMT using frozen fecal bacteria from a healthy donor. Similar bacterial taxa were found in post-transplantation samples obtained from the recipients and donor samples, but the relative abundance varied considerably between patients and time points. Post FMT samples from patients showed an increase in the abundance of Firmicutes and Bacteroidetes, representing 75-80% of the total sequence reads. Proteobacteria and Actinobacteria were less abundant (< 5%) than that found in patients prior to FMT. Post FMT samples from two patients were very similar to donor samples, with the Bacteroidetes phylum represented by a great abundance of members of the families Bacteroidaceae, Rikenellaceae and Porphyromonadaceae, and were largely comprised of Bacteroides, Alistipes and Parabacteroides genera. Members of the phylum Firmicutes were represented by Ruminococcaceae, Lachnospiraceae, Verrucomicrobiaceae and unclassified Clostridiales and members of the Firmicutes. One patient subsequently received antibiotics for an unrelated infection, resulting in an increase in the number of intestinal Proteobacteria, primarily Enterobacteriaceae. Our results demonstrate that frozen fecal microbiota from a healthy donor can be used to effectively treat recurrent CDI resulting in restoration of the structure of gut microbiota and clearing of Clostridum difficile.

Keywords: Clostridium difficile; DNA sequence analysis; Illumina; bacteroides; curing; fecal microbial transplantation; firmicutes; frozen preparations; microbiota; restoration.

PubMed Disclaimer

Figures

None
Figure 1. Bar charts showing the taxonomic classification and the relative abundance of OTUs. All taxa shown are represented by ≥ 0.5% of the total sequence reads. Phylum and family level classifications are shown in panels (A), (B) and (C) and (D), (E) and (F), respectively. All taxa represented by < 0.5% were added together and shown as Less Abundant Taxa. Samples are listed by patient number and days pre (-) and post (+) FMT.
None
Figure 2. Heatmap comparison of the abundance of the top 20 OTUs across samples. All sequence data were used to calculate the top 20 most abundant OTUs, rather than the most abundant OTUs in a given sample. Samples are listed by patient number and days pre (-) and post (+) FMT.
None
Figure 3. Principal coordinate plots generated using the Unifrac algorithm for individual patient data sets. Samples were normalized and abundance weighting was used in the analysis. Data for patients 1, 2 and 3 are shown in panels (A), (B) and (C), respectively. Samples are listed by days pre (-) and post (+) FMT. The percent variance explained by each axis is shown in the axis labels.

References

    1. Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev. 2010;23:529–49. doi: 10.1128/CMR.00082-09. - DOI - PMC - PubMed
    1. Jarvis WR, Schlosser J, Jarvis AA, Chinn RY. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Am J Infect Control. 2009;37:263–70. doi: 10.1016/j.ajic.2009.01.001. - DOI - PubMed
    1. Kelly CP, LaMont JT. Clostridium difficile--more difficult than ever. N Engl J Med. 2008;359:1932–40. doi: 10.1056/NEJMra0707500. - DOI - PubMed
    1. Kuijper EJ, Barbut F, Brazier JS, Kleinkauf N, Eckmanns T, Lambert ML, et al. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill. 2008;13 - PubMed
    1. McMullen KM, Mayfield JL, Abdul-Hakim A, Warren DK, Dubberke ER. Assessing colectomies due to Clostridium difficile infection: increases in the community, but not in the referral center. Am J Infect Control. 2012;40:778–80. doi: 10.1016/j.ajic.2011.09.010. - DOI - PubMed

Publication types